Article
Protective Effect of Glucocorticoids against Symptomatic Disease in CSF1R Variant Carriers.
Movement disorders : official journal of the Movement Disorder Society - 1 Aug 2023
Dulski Jarosław, Heckman Michael G, Nowak Julia M, Wszolek Zbigniew K
Abstract excerpt
BACKGROUND: There is an unmet need for the treatment of colony-stimulating factor-1 receptor (CSF1R)-related leukoencephalopathy. OBJECTIVES: To evaluate the association of glucocorticoids (GCs) with disease onset and progression in CSF1R variant carriers. METHODS: Retrospective cohort study on CSF1R variants carriers (n = 41) whose medical records were collected at Mayo Clinic Florida from 2003 to 2023. We...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
